ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer-Reference-Cited by-同舟云学术

ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer

Published:2024-04-02 Issue:6 Volume:31 Page:3914-3915
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Omura Minami,Kosaka Takeo^ORCID,Kobayashi Hiroaki,Shigeta Keisuke,Matsumoto Kazuhiro,Hara Satoshi,Kikuchi Eiji,Mikami Shuji,Saya Hideyuki,Sato Yasufumi,Oya Mototsugu

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Japanese Urological Association

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15122-1.pdf

Reference5 articles.

1. Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016. https://doi.org/10.1634/theoncologist.2015-0440.

2. Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest. 2004. https://doi.org/10.1172/JCI21152.

3. Zhang B, Wu Z, Xie W, et al. The expression of vasohibin-1 and its prognostic significance in bladder cancer. Exp Ther Med. 2017. https://doi.org/10.3892/etm.2017.4969.

4. Omura M, Kosaka T, Kobayashi H, et al. Vasohibin-1 expression can predict pathological complete remission of advanced bladder cancer with neoadjuvant chemotherapy. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15009-1.

5. Fukui Y, Nakamura K, Hirabayashi M, et al. Serum vasohibin-1 levels: a potential marker of dermal and pulmonary fibrosis in systemic sclerosis. Exp Dermatol. 2021. https://doi.org/10.1111/exd.14321.